GBSG‐GABG 6.
Study name | GABG‐6. |
Methods | |
Participants | Women aged 18 to 75 with histologically confirmed first isolated (that is non‐ metastasised) resectable (R0, R1) local and/or regional recurrence of invasive breast cancer, following mastectomy or breast ‐conserving therapy. |
Interventions | All women receive local radiotherapy if required. Randomised interventions: 1. control; 2. doxorubicin (50 mg/m2) + docetaxel (75 mg/m2) every 3 weeks x 4. |
Outcomes | Disease free survival. Overall survival. Quality of life. |
Starting date | October 1998. |
Contact information | Dr. H.F. Rauschecker Westermayerstr. 18, D‐83022 Rosenheim Germany Phone: +49‐8031‐ 219990 Fax: +49‐8031‐381367 Email: rauschecker@t‐online.de |
Notes | Randomisation by telephone. Target accrual: 500. |